HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.

AuthorsKazuhisa Hirahara, Yoko Kano, Yohei Sato, Chiho Horie, Aki Okazaki, Tadashi Ishida, Yumi Aoyama, Tetsuo Shiohara
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 69 Issue 3 Pg. 496-8 (Sep 2013) ISSN: 1097-6787 [Electronic] United States
PMID23957982 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Biomarkers
  • Cytokines
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interferon-gamma
  • Methylprednisolone
Topics
  • Adult
  • Aged
  • Anti-Inflammatory Agents (administration & dosage, therapeutic use)
  • Biomarkers (blood)
  • Cytokines (blood)
  • Female
  • Humans
  • Interferon-gamma (blood)
  • Interleukin-10 (blood)
  • Interleukin-6 (blood)
  • Male
  • Methylprednisolone (administration & dosage, therapeutic use)
  • Middle Aged
  • Re-Epithelialization
  • Retrospective Studies
  • Severity of Illness Index
  • Stevens-Johnson Syndrome (blood, drug therapy)
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: